Finding Value in Retail, Drug, Chemical Stocks
- Share via
The Value Line Investment Survey, a weekly publication that analyzes 1,700 stocks, has upgraded five companies to its top “timeliness” ranking based on projected gains in the coming 12 months.
Bumped up in the latest issue of Value Line, whose top picks have a history of outperforming the broad market, were retailers Bed Bath & Beyond and Tandy, drug companies Mylan Labs and Pharmaceutical Product Development and specialty chemical company MacDermid.
Knocked out of the top tier were Anchor Gaming, Jones Pharmaceuticals, Kmart, Kansas City Southern and Robert Half International.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
